Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis-Reference-Cited by-同舟云学术

Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis

Published:2022-02-07 Issue:5 Volume:37 Page:782-794
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Yuan Bao‐Hong¹,Li Ru‐Hong¹,Huo Rong‐Rui²,Li Min‐Jun²,Papatheodoridis George³^ORCID,Zhong Jian‐Hong²^ORCID

Affiliation:

1. Department of General Surgery Yan'An Hospital Affiliated to Kunming Medical University, The Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province Kunming China

2. Department of Hepatobiliary Surgery Guangxi Medical University Cancer Hospital Nanning China

3. Department of Gastroenterology, Medical School National and Kapodistrian University of Athens, General Hospitalof Athens “Laiko” Athens Greece

Funder

Natural Science Foundation of Guangxi Province

Bagui Scholars Program of Guangxi Zhuang Autonomous Region

National Natural Science Foundation of China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15783

Reference52 articles.

1. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

2. Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

5. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma;Computational and Structural Biotechnology Journal;2024-12

2. A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma;Frontiers in Pharmacology;2024-08-09

3. Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study;Infectious Agents and Cancer;2024-05-01

4. Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions;Journal of Clinical and Translational Hepatology;2024-04-24

5. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis;Cancers;2024-04-15